Xtx Topco LTD Bluebird Bio, Inc. Transaction History

Xtx Topco LTD

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	BUY	$0.91 - $1.75 $217,467 - $418,206	238,975 Added 1262.28%	257,907 $330,000
Q4 2023 Feb 13, 2024	BUY	$1.32 - $4.83 $24,990 - $91,441	18,932 New	18,932 $26,000
Q1 2022 May 13, 2022	SELL	$4.07 - $10.6 $68,087 - $177,327	-16,729 Closed	0 $0
Q4 2021 Feb 11, 2022	BUY	$8.96 - $16.31 $149,891 - $272,849	16,729 New	16,729 $167,000
Q3 2021 Nov 12, 2021	SELL	$11.24 - $21.0 $155,123 - $289,821	-13,801 Closed	0 $0
Q2 2021 Aug 12, 2021	BUY	$18.04 - $22.09 $248,970 - $304,864	13,801 New	13,801 $441,000

151

63.4M

264K

428K

Ticker BLUE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 77,121,800
Market Cap $27M
Description
bluebird bio, Inc., a biotechnology company, researches, develops, and commercializes transformative gene therapies for severe genetic diseases. Its product candidates for severe genetic diseases include betibeglogene autotemcel for the treatment of transfusion-dependent ß-thalassemia; lovotibeglogene autotemcel for the treatment of sickle cell ...

Get notified when there are updates to the investment portfolio of Xtx Topco LTD, based on Form 13F filings with the SEC.

Stay updated on Xtx Topco LTD with notifications on news.